000			05565cam a2200457Mi 4500
988			_aSpringer_Medicine_2017
999			_c96395 _d96395 _x1
001			96395
003			ES-MaUEC
005			20230102112752.0
006			m o d
007			cr cnu---unuuu
008			170805s2017 sz o 000 0 eng d
020			_a3319560425 _q(electronic bk.)
020			_a9783319560427 _q(electronic bk.)
020			_z3319560409
020			_z9783319560403
040			_aEBLCP _cEBLCP _dYDX _dN$T _dGW5XE _dOCLCO _dOCLCF _dUAB _dAZU _dUPM _dOCLCQ _dMERER _dOCLCQ _dESU _dIOG _dCOO _dES-MaUEC _bspa
050		4	_aRC669 _b2017 EB
245	0	0	_aCardio-Nephrology : _bConfluence of the Heart and Kidney in Clinical Practice _cJanani Rangaswami, Edgar V. Lerma, Claudio Ronco, editors.
264		1	_aCham _bSpringer _c2017.
300			_a1 recurso en línea (426 páginas)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
500			_aInterventions for CKD-Associated Cardiomyopathy.
500			_aSpringerLink
505	0		_6880-01 _aForeword; Preface; Contents; Contributors; Cardiovascular Disease Spectrum in Chronic Kidney Disease; 1 Endothelial Dysfunction and Nitric Oxide: Albuminuria as a Central Marker; Endothelial Function; Endothelial Activation and Endothelial Dysfunction; Evaluation of Endothelial Dysfunction; Nitric Oxide and Endothelium; Albuminuria and Endothelium; Albuminuria and Cardiovascular Disease; Summary; References; 2 Vascular and Valvular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Outcomes; Introduction; Vascular Calcification; Valvular Calcification.
505	8		_a4 Coronary Artery Disease in CKD: Traditional and Nontraditional Risk Factors, Diagnosis and ManagementEpidemiology of CAD in CKD Patients; Pathophysiology; Traditional and Nontraditional Risk Factors; Clinical Presentation; Reduction of CAD Risk in CKD Patients; Medical Therapy; Statins; Blood Pressure Management; Antiplatelet Therapy; Revascularization in CKD Patients; Stable Angina; STEMI and NSTEMI; CABG Versus PCI in CKD Patients; References; 5 CKD Associated Cardiomyopathy: Molecular Mechanisms, Imaging Modalities, Disease Evolution and Interventions; Introduction; Molecular Mechanisms.
505	8		_aPathogenesis of Vascular CalcificationPathogenesis of Valvular Calcification; Pathogenesis of Vascular and Valvular Calcification in CKD and ESKD; Disturbance in Mineral Metabolism; Alteration in Inhibitory Regulation; Increase in Matrix Metalloproteinases (MMP); Chronic Inflammation; Mechanical Stress; Clinical Impact of Vascular Calcification; Medical Strategies to Prevent Calcification; Clinical Impact of Valvular Calcification; Aortic Valve; Mitral Valve; Conclusion; Disclosures; References; 3 Sudden Cardiac Death in CKD and ESKD: Risk Factors, Mechanisms, and Therapeutic Strategies.
505	8		_aRenin-Angiotensin-Aldosterone System (RAAS)Abnormal Calcium and Phosphate Metabolism; Phosphate; Fibroblast Growth Factor 23 (FGF-23); Parathyroid Hormone; Vitamin D; Hyperuricemia; Protein Bound Uremic Toxins; Cardiotonic Steroids; Insulin Resistance; Imaging Modalities in CKD-Associated Cardiomyopathy; Left Ventricular Mass; Myocardial Fibrosis; Late Enhancement Imaging; T1 Mapping; Gadolinium-Based Contrast Agents in CKD; Computed Tomography; Cardiac Magnetic Resonance as the Proposed Imaging Modality of Choice in CKD; Evolution of CKD-Associated Cardiomyopathy.
520	3		_aExtending from the outpatient management of cardiovascular and kidney disease, to hospital-based decision making in patients with cardio-renal disease and complex interfaces such as hemodialysis in patients with ventricular assist device support, this book serves as a single reference point for cardiology and nephrology clinicians and researchers dealing with the significant overlap areas between these two specialties. Chapters cover the physiology, biomarkers, therapeutic agents and full spectrum of these comorbidities and feature separate sections on cardiovascular and CKD evaluations, stratification of kidney transplant patients, lipid management in CKD, interventional strategies and hypertension. Leaders in cardiology, nephrology, hypertension and lipidology bring together the latest evidence with their collective clinical experience into this invaluable resource. This textbook is an essential resource for physicians and allied professionals practicing cardiology, nephrology, students and physician trainees, to deepen their understanding of this crucial field.
650		7	_9138557 _aCardiología _2embne
700			_aLerma, Edgar V. _988310
700	1		_aRangaswami, Janani.
700	1		_aRonco, Claudio.
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-56042-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
880	8		_6505-01/(S _aIntroductionDefining Sudden Cardiac Death and Establishing Risk Factors; SCD Event Rate in ESKD; Associated Factors and Mechanistic Hypotheses; Age; Coronary Artery Disease; Diabetes Mellitus; Left Ventricular Hypertrophy; Dialysis and Dialysis Modality; Hyper- and Hypokalemia; Hypomagnesemia; Therapeutic Strategies for SCD Prevention in ESKD; Implantable Cardioverter-Defibrillators (ICD); Revascularisation for Coronary Atheroma; Βeta-Blockade; Other Pharmacotherapeutic Options; Dialysis Prescription; Summary; References.
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI